Laurion Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Laurion Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,424	Closed	-$537K	–	1153
2020 Q2	$537K	Buy	+5,424	New	+$433K	0.01%	604
2019 Q3	–	Sell	-11,962	Closed	-$772K	–	1287
2019 Q2	$772K	Sell	11,962 -2,738	-19%	-$177K	0.01%	611
2019 Q1	$933K	Buy	+14,700	New	+$772K	0.01%	517
2015 Q2	–	Sell	-2,993	Closed	-$378K	–	692
2015 Q1	$378K	Buy	+2,993	New	+$389K	0.01%	272

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Laurion Capital Management's TNDM Position: Q3 2020 in Review

Laurion Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 5,424 shares — an estimated $537K sold.

Laurion Capital Management first reported a position in TNDM in Q1 2015 and held it in 4 quarters. The position peaked at $933K in Q1 2019. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

Laurion Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 5,424 Tandem Diabetes Care shares in Q3 2020, an estimated $537K.
Laurion Capital Management first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 4 quarters.
Laurion Capital Management's Tandem Diabetes Care position peaked at $933K in Q1 2019.
321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.